Renovacare Inc (RCAR) 1.6200 $RCAR CORRECTING and

New Post Public Reply Private Reply Replies (0) Message Board

Aug 16, 2016 at 11:01 PM

Renovacare Inc (RCAR) 1.6200 $RCAR

CORRECTING and REPLACING VIDEO Latest Test Results Bolster RenovaCare Strategy to Spray Stem Cells on Wounds and Burns for Rapid Healing
BusinessWire - Tue May 31, 10:29AM CDT
Please replace the video with the accompanying corrected video.

Latest Test Results Bolster RenovaCare Strategy to Spray Stem Cells on Wounds and Burns for Rapid Healing
BusinessWire - Tue May 31, 8:57AM CDT
RenovaCare, Inc., (OTCQB:RCAR) today announced positive spray test results demonstrating that its novel SkinGun(TM) technology achieves exceptionally-uniform distribution of fluids with 200 times greater coverage than conventional methods. These outcomes are especially promising to scientists developing patented RenovaCare CellMist(TM) and SkinGun(TM) technologies* for spraying fluids containing a patient's own stem cells onto burns and wounds for rapid scar-free healing.

New Study: RenovaCare SkinGun(TM) Ultra-Gently Sprays Human Stem Cells to Achieve 'Gold-Standard' Viability for Skin Regeneration
BusinessWire - Tue May 03, 8:15AM CDT
RenovaCare, Inc., (OTCQB:RCAR), a developer of novel medical grade liquid spray devices and patented CellMist(TM) and SkinGun(TM) technologies*, today announced favorable outcomes from laboratory studies conducted by Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charite - Universitatsmedizin Berlin, one of the world's largest university hospitals.

RenovaCare, Inc. Completes Engineering, Research, and Studies Required to File 510(k) Submission to the FDA for its Novel Medical-Grade Liquid Spray Device
BusinessWire - Tue Apr 12, 8:15AM CDT
RenovaCare, Inc., a developer of novel medical grade liquid spray devices and patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced that the company has successfully completed the engineering, studies, and associated efforts required for submission of its foundational 510(k) filing to the U.S. Food and Drug Administration (FDA). The company's planned submission will focus on its liquid sprayer technology. The FDA's clearance of a 510(k) submission allows for the marketing of a medical device in the United States.

RenovaCare, Inc. Names Renowned Skin Surgeon Steven Q. Wang, MD to Board of Advisors
BusinessWire - Tue Feb 09, 8:15AM CST
RenovaCare, Inc., developer of patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Steven Q. Wang to its Board of Advisors. Dr. Wang is Head of Dermatology Section and Director of Dermatologic Surgery and Dermatology at Memorial Sloan-Kettering Cancer Center in Basking Ridge, New Jersey.

Respected Plastic and Reconstructive Surgeon, Richard Simman, MD, Joins RenovaCare, Inc.
BusinessWire - Tue Jan 12, 8:15AM CST
RenovaCare, Inc., developer of the patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of board certified plastic and reconstructive surgeon, Richard Simman, MD, FACS, and FACCWS, to its Board of Advisors.

RenovaCare, Inc. Enters R&D Partnership with World Leading Charite
BusinessWire - Tue Nov 17, 8:15AM CST
RenovaCare, Inc. (OTCQB:RCAR), today announced a partnership to validate the science behind its groundbreaking technology for treatments of wounds, burns and other skin defects. The company's research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charite - Universitatsmedizin Berlin, one of the world's largest university hospitals.

RenovaCare elects Michael M. Barch to board of advisors
M2 - Fri Oct 16, 3:06AM CDT
Stem cell therapies company RenovaCare (OTC BB:RCAR) reported on Thursday the addition of Michael M. Barch to its board of advisors.

Accomplished Healthcare Executive, Michael M. Barch, Joins RenovaCare, Inc.
BusinessWire - Thu Oct 15, 8:15AM CDT
RenovaCare, Inc., (OTCQB:RCAR), developer of the patented CellMist(TM) and SkinGun(TM) technologies for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of healthcare executive and industry thought-leader, Michael M. Barch, to its Board of Advisors.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IRS Views Challenge Tax-Engineered Healthcare Schemes

Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...

Debbie's Dream Foundation Launches 2026 Youth Art Contest

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Sierra Ridge Advisors Join Gateway Financial Milestone

Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...

Digital Wine Atlas Maps 4.3 Million Vineyards Globally

Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...

Debt Crisis Looms: Social Security at Risk

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Celebrate National Service Dog Month with Canine Companions

A Month to Celebrate Unseen Heroes Take a pause. We're talking about National Service Dog Month. What in the world could be more endearing than a pack of puppies, those hopeful bundles of joy, destined to grow up and play pivotal roles in people's lives? Canine Companions is rolling out the red carpet for these future heroes, with a nine-day Puppy Cam event from September...

Crimson Coward's Cheez Nugs Shake Up Fast-Casual Scene

New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...

Menopause Policy Advocacy Takes Center Stage in DC

Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...

Buffett Steps Down, New Faces at Berkshire Hathaway

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

AI Ambassadors Rethink Arbitration's Future

Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...